Prime Herbonix Health Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 1.00 M
as on 12-12-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -2.28%
(FY 2020)
- Profit 47.20%
(FY 2020)
- Ebitda 28.61%
(FY 2020)
- Net Worth 20.48%
(FY 2020)
- Total Assets 7.43%
(FY 2020)
About Prime Herbonix Health Products
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Chaudhari and Yogini Chaudhari serve as directors at the Company.
- CIN/LLPIN
U67120PN1999PTC013766
- Company No.
013766
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Prime Herbonix Health Products Private Limited offer?
Prime Herbonix Health Products Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Juices, Soups & Soft Drinks, Instant Drink Mix, Nutraceuticals & Dietary Supplements, Mineral Supplement, Bakery & Confectionery Products, Candy & Jelly, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine.
Who are the key members and board of directors at Prime Herbonix Health Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Chaudhari  | Director | 28-Jun-1999 | Current |
| Yogini Chaudhari | Director | 10-Apr-2006 | Current |
Financial Performance of Prime Herbonix Health Products.
Prime Herbonix Health Products Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 2.28% decrease. The company also saw a substantial improvement in profitability, with a 47.2% increase in profit. The company's net worth Soared by an impressive increase of 20.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prime Herbonix Health Products?
In 2019, Prime Herbonix Health Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prime Herbonix Health Products?
Unlock and access historical data on people associated with Prime Herbonix Health Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prime Herbonix Health Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prime Herbonix Health Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
